Juvenile myasthenia gravis: Treatment with immune globulin and thymectomy

Pediatric Neurology

Volumn 18, Issue 1, 1998, Pages 63-66

  Herrmann, David N ^a   Carney, Paul R ^a,b   Wald, John J ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; IMMUNOMODULATING AGENT; PYRIDOSTIGMINE;

ADOLESCENT; ARTICLE; CASE REPORT; CHILD; CLINICAL EXAMINATION; DISEASE COURSE; FEMALE; HUMAN; IMMUNOTHERAPY; INTRAVENOUS DRUG ADMINISTRATION; MALE; MYASTHENIA GRAVIS; PRIORITY JOURNAL; THYMECTOMY; THYMUS HYPERPLASIA; TREATMENT OUTCOME;

EID: 0031917305     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-8994(97)00136-7     Document Type: Article

References (27)

1. [1] Fenichel GM. Myasthenia gravis. Pediatr Ann 1989;18:432-8.
2. [2] Rodriguez M, Gomez MR, Howard FM, Taylor WF. Myasthenia gravis in children: Long-term follow-up. Ann Neurol 1983;13: 504-10.
3. [3] Adams C, Theodorescu D, Murphy EG, Shandling B. Thymectomy in juvenile myasthenia gravis. J Child Neurol 1990;5:215-8.
4. [4] Drachman DB. Myasthenia gravis. N Engl J Med 1994;330: 1797-1810.
5. [5] Edan G, Landgraf F. Experience with intravenous immunoglobulin in myasthenia gravis: A review. J Neurol Neurosurg Psychiatry 1994;57(suppl):55-6.
6. [6] Gajdos PH. Intravenous immune globulin in myasthenia gravis. Clin Exp Immunol 1994;97(suppl 1):49-51.
7. [7] Pascuzzi RM, Coslett HB, Johns TR. Long term corticosteroid treatment of myasthenia gravis. Ann Neurol 1984;15:291-8.
8. [8] Cornelio F, Antozzi C, Mantegazza R, et al. Immunosuppressive treatments: Their efficacy on myasthenia gravis patients' outcome and on the natural course of the disease. Ann NY Acad Sci 1987;505:517-25.
9. [9] Sanders DB, Scoppetta C. The treatment of patients with myasthenia gravis. Neurol Clin 1994;12:343-68.
10. [10] Sarnat HB, McGarry JD, Lewis JE. Effective treatment of infantile myasthenia gravis by combined prednisone and thymectomy. Neurology 1977;27:550-3.
11. [11] Osserman KE, Genkins G. Studies in myasthenia gravis: Review of a twenty-year experience in over 1200 patients. Mt Sinai J Med 1971;38:497-534.
12. [12] Millichap JG, Dodge PR. Diagnosis and treatment of myasthenia gravis in infancy, childhood and adolescence: a study of 51 patients. Neurology 1960;10:1007-14.
13. [13] Avioli LV. Glucocorticoid effects on statural growth. Br J Rheumatol 1993;32(suppl 2):27-30.
14. [14] Brannagan TH, Nagle KJ, Lange DJ, Rowland LP. Complications of intravenous immune globulin treatment in neurologic disease. Neurology 1996;47:674-7.
15. [15] Yap PL. The viral safety of intravenous immune globulin. Clin Exp Immunol 1996;104(suppl 1):35-42.
16. [16] Sekul EA, Cupler EJ, Dalakas MC. Aseptic meningitis associated with high-dose intravenous immunoglobulin therapy: Frequency and risk factors. Ann Intern Med 1994;121:259-62.
17. [17] Tam DA, Morton LD, Stroncek DF, Leshner RT. Neutropenia in a patient receiving intravenous immune globulin. J Neuroimmunol 1996;64:175-8.
18. [18] Dodd RY. Infectious risk of plasma donations: Relationship to safety of intravenous immune globulins. Clin Exp Immunol 1996; 104(suppl 1):31-4.
19. [19] Batocchi AP, Evoli A, Palmisani MT, Lo Monaco M, Bartoccioni M, Tonali P. Early-onset myasthenia gravis: Clinical characteristics and response to therapy. Eur J Pediatr 1990;150:66-8.
20. [20] Andrews PI, Massey JM, Howard JF, Sanders DB. Race, sex, and puberty influence onset, severity, and outcome in juvenile myasthenia gravis. Neurology 1994;44:1208-14.
21. [21] Brearley S, Gentle TA, Baynham MID, Roberts KD, Abrams LD, Thompson RA. Immunodeficiency following neonatal thymectomy in man. Clin Exp Immunol 1987;70:322-7.
22. [22] Rubinstein A, Pelet B, Schweizer V. Immunological decay in thymectomized infants. Helv Paediatr Acta 1976;30:425-33.
23. [23] Bjorkholm M, Holm G, Johansson B, Mellstedt H. T-lymphocyte deficiency following adult thymectomy in man. Can J Haematol 1975;14:210-5.
24. [24] Seybold ES, Howard FM, Duane DD, Payne WS, Harrison EG. Thymectomy in juvenile myasthenia gravis. Arch Neurol 1971;25:385-92.
25. [25] Melms A, Malcherek G, Gern U, et al. Thymectomy and azathioprine have no effect on the phenotype of CD4 T lymphocyte subsets in myasthenia gravis. J Neurol Neurosurg Psychiatry 1993;56: 46-51.
26. [26] Thorlacius S, Aarli JA, Riise T, Matre R, Johnsen HJ. Associated disorders in myasthenia gravis: Autoimmune diseases and their relation to thymectomy. Acta Neurol Scand 1989;80:290-5.
27. [27] Masaoka A, Yamakawa Y, Niwa H, et al. Thymectomy and malignancy. Eur J Cardiothorac Surg 1994;8:251-3.